Search Results 2371-2380 of 16403 for Chronic Lymphocytic Leukemia

1. Lamivudine and tenofovir (oral route) - Mayo Clinic

   Kidney disease, severe—Use is not recommended in patients with these conditions. Back to top. Proper Use. Take this medicine exactly as directed by your ...

2. A Non-interventional Cohort Safety Study of Patients With hATTR-PN - Mayo Clinic

   About this study. The purpose of this study with the Health Authorities from the United States (US), Canada and Europe, is to collect long-term safety ...

3. shingles Archives - Mayo Clinic News Network

   ... chronic illness or other conditions; The rash is ... diagnosis and aggressive treatment with ... lymphatic system, such as leukemia or lymphoma; Are ...

4. A Study to Evaluate the Effectiveness and Safety of MEDI2070 in Subjects with Active Moderate to Severe Crohn's Disease - Mayo Clinic

   A Study to Evaluate the Effectiveness and Safety of MEDI2070 in Subjects with Active Moderate to Severe Crohn's Disease · More about research at Mayo Clinic.

5. Study to Assess the Effectiveness and Safety of Bradanicline in Patients with Chronic Cough - Mayo Clinic

   Study to Assess the Effectiveness and Safety of Bradanicline in Patients with Chronic Cough · Overview · Participation eligibility · Participating Mayo Clinic ...

6. Thrombocytosis Clinical Trials - Mayo Clinic Research

   This open-label study is to determine the long-term safety and tolerability of momelotinib in previously enrolled study participants with primary myelofibrosis ...

7. Efficacy and Safety Study of Mepolizumab in Subjects With Severe Hypereosinophilic Syndrome (HES) - Mayo Clinic

   About this study. Mepolizumab is a humanized monoclonal antibody. In conditions where eosinophilia is considered to play an important part in the pathology, ...

8. Blood and Marrow Stem Cell Transplantation Clinic in Minnesota - Overview

   Chronic graft-versus-host disease. Medicine rashes. Infectious rashes. Undiagnosed rashes. Skin involvement by underlying leukemia or lymphoma. Contact.

9. A Study Comparing Temozolomide and Selumetinib for Treating Patients with Metastatic Melanoma of the Eye - Mayo Clinic

   Selumetinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. It is not yet known whether temozolomide is more ...

10. Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients - Mayo Clinic

    Participation eligibility · Prior diagnosis of Stage I, IIA, IIB, IIC, or III melanoma · Surgical resection within 90 days of first dosing · Persons with positive ...